Home › Shareholders OK Mylan's inversion deal with Abbott
 

Keywords :   


Shareholders OK Mylan's inversion deal with Abbott

2015-01-29 20:51:09| Biotech - Topix.net

Mylan Inc. shareholders voted Thursday to approve the company's pending acquisition of Abbott's non-U.S. developed markets specialty and branded generic business and reorganization in the Netherlands. Announced in July, the $5.3 billion all-stock transaction gives Abbott a 22 percent stake in Mylan and will move its generic business to a new company that will be headquartered in the tax-friendly Netherlands and called New Mylan.

Tags: deal shareholders abbott inversion

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05'Time running out' plea over shipyard's future
16.05Eastern North Pacific Tropical Weather Outlook
16.05Atlantic Tropical Weather Outlook
16.05China's Nio unveils Tesla Model Y rival
16.05Could the US economy be doing too well?
16.05Eastern North Pacific Tropical Weather Outlook
16.05Atlantic Tropical Weather Outlook
16.05The man who turned his dead father into a chatbot
More »